New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - varicella vaccine 2000 pfu (not less than); varicella vaccine 2000 pfu (not less than) - powder for injection with diluent - 2000 pfu - active: varicella vaccine 2000 pfu (not less than) excipient: albumin amino acids lactose monohydrate mannitol sorbitol water for injection active: varicella vaccine 2000 pfu (not less than) excipient: amino acids lactose mannitol sorbitol - varilrix is indicated for active immunisation and prophylaxis against varicella in healthy infants (from the age of 9 months), children, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - measles vaccine, schwarz strain 1000 ccid50 (not less than); mumps virus, live attenuated, rit 4385 5012 ccid50 (not less than);  ; rubella virus, wistar ra27/3 strain 1000 ccid50 (not less than) - powder for injection with diluent - 0.5 ml - active: measles vaccine, schwarz strain 1000 ccid50 (not less than) mumps virus, live attenuated, rit 4385 5012 ccid50 (not less than)   rubella virus, wistar ra27/3 strain 1000 ccid50 (not less than) excipient: amino acids lactose mannitol sorbitol water for injection - priorix is indicated for the active immunisation against measles, mumps and rubella.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - pneumococcal polysaccharide serotype 1 1ug (conjugated with nthi protein d);  ;  ; pneumococcal polysaccharide serotype 14 1ug (conjugated with nthi protein d);  ;  ; pneumococcal polysaccharide serotype 18c 3ug (conjugated with tetanus toxoid);  ;  ; pneumococcal polysaccharide serotype 19f 3ug (conjugated with diptheria toxoid);  ;  ; pneumococcal polysaccharide serotype 23f 1ug (conjugated with nthi protein d);  ;  ; pneumococcal polysaccharide serotype 4 3ug (conjugated with nthi protein d);  ;  ; pneumococcal polysaccharide serotype 5 1ug (conjugated with nthi protein d);  ;  ; pneumococcal polysaccharide serotype 6b 1ug (conjugated with nthi protein d);  ;  ; pneumococcal polysaccharide serotype 7f 1ug (conjugated with nthi protein d);  ;  ; pneumococcal polysaccharide serotype 9v 1ug (conjugated with nthi protein d);  ;   - suspension for injection - active: pneumococcal polysaccharide serotype 1 1ug (conjugated with nthi protein d)     pneumococcal polysaccharide serotype 14 1ug (conjugated with nthi protein d)     pneumococcal polysaccharide serotype 18c 3ug (conjugated with tetanus toxoid)     pneumococcal polysaccharide serotype 19f 3ug (conjugated with diptheria toxoid)     pneumococcal polysaccharide serotype 23f 1ug (conjugated with nthi protein d)     pneumococcal polysaccharide serotype 4 3ug (conjugated with nthi protein d)     pneumococcal polysaccharide serotype 5 1ug (conjugated with nthi protein d)     pneumococcal polysaccharide serotype 6b 1ug (conjugated with nthi protein d)     pneumococcal polysaccharide serotype 7f 1ug (conjugated with nthi protein d)     pneumococcal polysaccharide serotype 9v 1ug (conjugated with nthi protein d)     excipient: aluminium phosphate diphtheria toxoid, adsorbed haemophilus influenzae protein d sodium chloride tetanus toxoid water for injection - synflorix is indicated for the active immunisation of infants and children from the age of 6 weeks up to 5 years against disease caused by streptococcus pneumoniae vaccine serotypes 1, 4, 5, 6b, 7f, 9v, 14, 18c, 19f, 23f and cross-reactive serotype 19a (including invasive disease, pneumonia and acute otitis media).

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180); influenza virus a/switzerland/8060/2017 (h3n2) like strain 15ug (a/brisbane/1/2018, nymc x-311); influenza virus b/colorado/06/2017 - like strain 15ug (b/maryland/15/2016, nymc bx-69a (victoria lineage)); influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type (yamagata lineage)) - suspension for injection - 0.5 ml - active: influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180) influenza virus a/switzerland/8060/2017 (h3n2) like strain 15ug (a/brisbane/1/2018, nymc x-311) influenza virus b/colorado/06/2017 - like strain 15ug (b/maryland/15/2016, nymc bx-69a (victoria lineage)) influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type (yamagata lineage)) excipient: d-alpha-tocopheryl acid succinate dibasic sodium phosphate dodecahydrate magnesium chloride hexahydrate monobasic potassium phosphate octoxinol polysorbate 80 potassium chloride sodium chloride water for injection - fluarix tetra is a quadrivalent vaccine indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the influenza virus types a and b contained in the vaccine. the use of fluarix tetra should be based on official recommendations.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamivudine 100mg;   - film coated tablet - 100 mg - active: lamivudine 100mg   excipient: magnesium stearate opadry butterscotch ys-1r-17307-a powdered cellulose sodium starch glycolate - zeffix is indicated for the treatment of adults and children aged 2 years and older with chronic hepatitis b and evidence of hepatitis b viruse (hbv) replication.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 3%{relative} - eye ointment - 3% w/w - active: aciclovir 3%{relative} excipient: white soft paraffin - treatment of herpes simplex keratitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - cefuroxime sodium 262.5mg equivalent to 250 mg cefuroxime - powder for injection - 250 mg - active: cefuroxime sodium 262.5mg equivalent to 250 mg cefuroxime

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - abacavir sulfate 702mg equivalent to abacavir 600 mg;  ;  ; lamivudine 300mg;   - film coated tablet - 600mg/300mg - active: abacavir sulfate 702mg equivalent to abacavir 600 mg     lamivudine 300mg   excipient: magnesium stearate microcrystalline cellulose opadry orange ys-1-13065a sodium starch glycolate - kivexa is a combination of two nucleoside analogues (abacavir and lamivudine). it is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg;  ; valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg - film coated tablet - 500 mg - active: valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg   excipient: carnauba wax colloidal silicon dioxide crospovidone edible ink blue brilliant 5312 magnesium stearate microcrystalline cellulose opadry white ys1-18043 povidone purified water   active: valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg excipient: carnauba wax colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry white ys1-18043 povidone purified water   - · valtrex is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - paroxetine hydrochloride 22.8mg equivalent to 20 mg paroxetine;   - film coated tablet - 20 mg - active: paroxetine hydrochloride 22.8mg equivalent to 20 mg paroxetine   excipient: calcium hydrogen phosphate dihydrate magnesium stearate opadry white ys-1-7003 sodium starch glycolate - aropax is indicated for the treatment of major depressive disorder (mdd). aropax is indicated for the prevention of relapse and also recurrence of further depressive episodes.